Skip to content

Supplier News

CEO succession, new COO at Prasco

Christopher Arington has been promoted to vice chairman and chief executive officer of authorized generic drug maker Prasco Laboratories. Previously president and chief operating officer, he takes the CEO reins from his father, Prasco chairman and founder E. Thomas Arington.

Nipro honored as a top manufacturer in Florida

Nipro Diagnostics Inc. has won the 2011 Manufacturer of the Year Award from the Manufacturers Association of Florida (MAF). The diabetes management product company said Monday that it was recognized in the large company category (more than 500 employees).

Crossmark set to acquire NCiM

Consumer product sales and marketing specialist Crossmark plans to buy national marketing agency New Concepts in Marketing Inc. (NCiM). Terms of the deal weren’t disclosed.

Ranbaxy, Teva in accord on Lipitor generic

Ranbaxy Laboratories Ltd. and Teva Pharmaceuticals USA Inc. have entered an agreement on their respectives launches of generic versions of Lipitor, Pfizer’s cholesterol-reducing medication. Jerusalem-based Teva Pharmaceutical Industries Ltd.

Authorized generic Lipitor rolled out by Watson

In what it called the largest generic product launch in U.S. history, Watson Pharmaceuticals Inc. has begun shipping an authorized generic version of Pfizer’s blockbuster cholesterol-lowering drug Lipitor. The shipment of Watson’s Lipitor generic signals the start of the "generic wave.

Qualitest cleared to market Myzilra tablets

Qualitest Pharmaceuticals has received approval from the Food and Drug Administration for Myzilra tablets, an oral contraceptive. The company said Monday that the FDA approved Myzilra tablets (levonorgestrel and ethinyl estradiol) 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, 0.125 mg/0.

P&G portal unites beauty and fashion

Procter & Gamble Co.’s P&G Beauty & Grooming unit has launched of StyleUnited, which it called "the first truly personalized site" that brings beauty and fashion together to provide "a total style resource." P&G said Tuesday that styleunited.

Perrigo gets FDA OK for Mucinex generic

Perrigo Co. has received final approval from the Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for guaifenesin extended-release tablets (600 mg), indicated for chest congestion.

Pfizer inks deal to buy Excaliard

Pfizer Inc. has agreed to acquire Excaliard Pharmaceuticals Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, or skin scarring.